The In Vitro and Animal Models for Emerging Diseases and Biodefense contract provides the development and standardization of small animal and non-human primate models, and may include efficacy testing of vaccines and/or therapeutics, including GLP studies to support product licensure. Vaccines and therapeutics which are efficacious in small animals may be further tested in non-human primate models. This contract also provides testing of vaccines for safety and immunogenicity, to include humoral and cellular immunity, in small animals as well as non-human primates, under GLP where appropriate.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
N01AI30062-30-0-1
Application #
8882966
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Public Health England
Department
Type
DUNS #
City
Salisbury
State
Country
United Kingdom
Zip Code